Use of Non-invasive Optical Analysis in Neurosurgery
Brain Tumour, Glioma, Meningioma
About this trial
This is an interventional other trial for Brain Tumour focused on measuring gliomas, multispectral analysis, hyperspectral analysis, fluorescence, brain tumours
Eligibility Criteria
Inclusion Criteria:
- Candidates for surgery due to a confirmed clinical and radiological diagnosis of cranial intrinsic or extrinsic tumour - any histological diagnosis confirming neuro-oncological disease, including primary and secondary disease
- Agreed to take part to the present research protocol and signed proper informed consent form
Exclusion Criteria:
- Suspected differential diagnosis of pathological condition affecting central nervous system other than neuro-oncological disease - including demyelinating diseases, infections, brain traumas / haematomas, vascular or auto-immune diseases
- Patients not capable to give consent - not in condition of understanding, processing and retaining information
Sites / Locations
- Imperial College NHS Trust, Charing Cross HospitalRecruiting
Arms of the Study
Arm 1
Experimental
Patients with brain tumours candidate for neurosurgery
Patients will be recruited following the inclusion criteria: any patient with a diagnosis of brain tumour, age ranging from 18 with no upper limit, who will agree to the operation and to take part of the present study, will be enrolled. During surgery, multispectral and/or hyper spectral acquisition of images from the surgical field will be performed. Each patient will have an average acquisition of 6 datasets. As each dataset will correspond to an image, this will be divided into many reading regions (from 10 to 20) for a total of approximatively 60 measurements per patient.